Genetic alterations of chromosome 8 genes in oral cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yong, Zachary Wei Ern ^a   Zaini, Zuraiza Mohamad ^a   Kallarakkal, Thomas George ^a   Karen Ng, Lee Peng ^a   Rahman, Zainal Ariff Abdul ^a   Ismail, Siti Mazlipah ^a   Sharifah, Noor Akmal ^b   Mustafa, Wan Mahadzir Wan ^c   Abraham, Mannil Thomas ^d   Tay, Keng Kiong ^e   Zain, Rosnah Binti ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c HOSPITAL KUALA LUMPUR   (Malaysia)

^d Hospital Tengku Ampuan Rahimah   (Malaysia)

^e Hospital Umum Sarawak   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE N-ACETYLGALACTOSAMINYLTRANSFERASE-1; FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GATA4 PROTEIN, HUMAN; METHIONINE SULFOXIDE REDUCTASE; N ACETYLGALACTOSAMINYLTRANSFERASE; TRANSCRIPTION FACTOR GATA 4;

CHROMOSOME 8; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; FEMALE; GENE DOSAGE; GENETICS; HUMAN; MALE; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; DNA COPY NUMBER VARIATIONS; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE DOSAGE; HUMANS; MALE; METHIONINE SULFOXIDE REDUCTASES; MOUTH NEOPLASMS; N-ACETYLGALACTOSAMINYLTRANSFERASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

EID: 84906278783     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06073     Document Type: Article

References (60)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90, doi:10.3322/ caac.20107 (2011).
2. Scully, C. &Bedi, R. Ethnicity and oral cancer. Lancet Oncol. 1, 37-42, doi:10.1016/S1470-2045(00)00008-5 (2000).
3. Petti, S. Lifestyle risk factors for oral cancer. Oral Oncol. 45, 340-350, doi:10.1016/ j.oraloncology.2008.05.018 (2009).
4. Califano, J. et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56, 2488-2492 (1996). (Pubitemid 26170679)
5. Braakhuis, B. J., Tabor, M. P., Kummer, J. A., Leemans, C. R.& Brakenhoff, R. H.A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 63, 1727-1730 (2003). (Pubitemid 36460827)
6. Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23-28 (1976).
7. Pathare, S., Schaffer, A. A., Beerenwinkel, N. &Mahimkar, M. Construction of oncogenetic tree models reveals multiple pathways of oral cancer progression. Int. J. Cancer 124, 2864-2871, doi:10.1002/ijc.24267 (2009).
8. Zhou, X. et al. Allelic imbalance analysis of oral tongue squamous cell carcinoma by high-density single nucleotide polymorphism arrays using whole-genome amplified DNA. Hum. Genet. 118, 504-507, doi:10.1007/s00439-005- 0069-x (2005). (Pubitemid 43091222)
9. Yoshioka, S. et al. Genomic profiling of oral squamous cell carcinoma by arraybased comparative genomic hybridization. PLoS One 8, e56165, doi:10.1371/ journal.pone.0056165 (2013).
10. Vincent-Chong, V. K. et al. Genome-wide analysis of oral squamous cell carcinomas revealed over expression of ISG15, Nestin and WNT11. Oral Dis. 18, 469-476, doi:10.1111/j.1601-0825.2011.01894.x (2012).
11. Moelans, C. B., de Weger, R. A., Monsuur, H. N., Vijzelaar, R. &van Diest, P. J. Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes. Mod. Pathol. 23, 1029-1039, doi:10.1038/modpathol. 2010.84 (2010).
12. Freier, K. et al. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncol. 43, 60-66, doi:10.1016/j.oraloncology.2006.01.005 (2007). (Pubitemid 46162249)
13. Chen, Y. J. et al. Genome-wide profiling of oral squamous cell carcinoma. J. Pathol. 204, 326-332, doi:10.1002/path.1640 (2004). (Pubitemid 39430093)
14. Wu, C. L. et al. Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosom. Cancer 20, 347-353 (1997). (Pubitemid 27520083)
15. El-Naggar, A. K. et al. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma. Oncogene 16, 2983-2987, doi:10.1038/sj.onc.1201808 (1998). (Pubitemid 28297719)
16. Ono, K. et al. Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas. Int. J. Oncol. 23, 297-302 (2003).
17. Schouten, J. P. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).
18. Leemans, C. R., Braakhuis, B. J.& Brakenhoff, R. H. Themolecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22, doi:10.1038/nrc2982 (2011).
19. Bremmer, J. F. et al. Screening for oral precancer with noninvasive genetic cytology. Cancer Prev. Res. (Phila.) 2, 128-133, doi:10.1158/1940-6207. CAPR-08- 0128 (2009).
20. Sethi, S., Benninger, M. S., Lu, M., Havard, S. &Worsham, M. J. Noninvasive molecular detection of head and neck squamous cell carcinoma: an exploratory analysis. Diagn. Mol. Pathol. 18, 81-87, doi:10.1097/PDM. 0b013e3181804b82 (2009).
21. Hughes, S., Williams, R. D.,Webb, E. &Houlston, R. S.Meta-analysis and pooled re-analysis of copy number changes in colorectal cancer detected by comparative genomic hybridization. Anticancer Res. 26, 3439-3444 (2006). (Pubitemid 44701520)
22. El Gammal, A. T. et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin. Cancer Res. 16, 56-64, doi:10.1158/1078-0432.CCR-09-1423 (2010).
23. Buffart, T. E. et al. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch. 455, 213-223, doi:10.1007/s00428-009-0814-y (2009).
24. Marchetti, A., Buttitta, F., Pellegrini, S., Bertacca, G. &Callahan, R. Reduced expression of INT-6/eIF3-p48 in human tumors. Int. J. Oncol. 18, 175-179 (2001).
25. Rasmussen, S. B., Kordon, E., Callahan, R. &Smith, G. H. Evidence for the transforming activity of a truncated Int6 gene, in vitro. Oncogene 20, 5291-5301, doi:10.1038/sj.onc.1204624 (2001). (Pubitemid 32844061)
26. Mayeur, G. L. &Hershey, J. W. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 514, 49-54 (2002). (Pubitemid 34251241)
27. Buttitta, F. et al. Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin. Cancer Res. 11, 3198-3204, doi:10.1158/1078- 0432.CCR-04-2308 (2005). (Pubitemid 40627865)
28. Dong, Z.&Zhang, J. T. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit. Rev. Oncol. Hematol. 59, 169-180, doi:10.1016/ j.critrevonc.2006.03.005 (2006). (Pubitemid 44294864)
29. Grzmil, M. et al. An oncogenic role of eIF3e/INT6 in human breast cancer. Oncogene 29, 4080-4089, doi:10.1038/onc.2010.152 (2010).
30. Sesen, J. et al. Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells. Int JMol Sci 15, 2172-2190, doi:10.3390/ ijms15022172 (2014).
31. Buffart, T. E. et al. DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell. Oncol. 27, 57-65 (2005). (Pubitemid 40387193)
32. Rodrigo, J. P., Lazo, P. S., Ramos, S., Alvarez, I. &Suarez, C. MYC amplification in squamous cell carcinomas of the head and neck. Arch. Otolaryngol. Head Neck Surg. 122, 504-507 (1996). (Pubitemid 26153860)
33. Bhattacharya, N., Roy, A., Roy, B., Roychoudhury, S. &Panda, C. K. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients. J. Oral Pathol. Med. 38, 759-763, doi:10.1111/ j.1600-0714.2009.00781.x (2009).
34. Mohaghegh, P. &Hickson, I. D. DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders. Hum. Mol. Genet. 10, 741-746 (2001). (Pubitemid 32331583)
35. Thomassen, M., Tan, Q. &Kruse, T. A. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res. Treat. 113, 239-249, doi:10.1007/s10549-008-9927- 2 (2009).
36. Saglam, O., Shah, V. &Worsham,M. J.Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis. Diagn. Mol. Pathol. 16, 218-221, doi:10.1097/PDM.0b013e3180d0aab5 (2007). (Pubitemid 350196979)
37. Narayan, G. et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosom. Cancer 46, 373-384, doi:10.1002/gcc.20418 (2007). (Pubitemid 46411328)
38. Swartz, C. D., Afshari, C. A., Yu, L., Hall, K. E. &Dixon, D. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol. Hum. Reprod. 11, 441-450, doi:10.1093/molehr/gah174 (2005). (Pubitemid 41430098)
39. Fujiwara, Y. et al. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res. 53, 1172-1174 (1993). (Pubitemid 23087925)
40. Hellebrekers, D. M. et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin. Cancer Res. 15, 3990-3997, doi:10.1158/1078-0432.CCR-09-0055 (2009).
41. Lassus, H. et al. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab. Invest. 81, 517-526 (2001). (Pubitemid 32298797)
42. Bai, Y. et al. Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines. Mol. Carcinog. 28, 184-188 (2000). (Pubitemid 30612998)
43. Akiyama, Y. et al. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol. Cell. Biol. 23, 8429-8439 (2003). (Pubitemid 37433351)
44. Lin, L. et al. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. Cancer Res. 60, 1341-1347 (2000). (Pubitemid 30152004)
45. Yang, S. et al. Identification of genes with correlated patterns of variations inDNA copy number and gene expression level in gastric cancer. Genomics 89, 451-459, doi:10.1016/j.ygeno.2006.12.001 (2007). (Pubitemid 46413666)
46. Dailey, L., Ambrosetti, D.,Mansukhani, A. &Basilico, C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16, 233-247, doi:10.1016/j.cytogfr.2005.01.007 (2005). (Pubitemid 40616120)
47. Courjal, F. et al.Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res. 57, 4360-4367 (1997). (Pubitemid 27413447)
48. Gorringe, K. L. et al. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clin. Cancer Res. 13, 4731-4739, doi:10.1158/1078-0432.CCR-07- 0502 (2007). (Pubitemid 47294779)
49. Missiaglia, E. et al. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development. Genes Chromosom. Cancer 48, 455-467, doi:10.1002/gcc.20655 (2009).
50. Simon, R. et al. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res. 61, 4514-4519 (2001). (Pubitemid 32685782)
51. Kohler, L. H. et al. FGFR1 expression and gene copy numbers in human lung cancer. Virchows Arch. 461, 49-57, doi:10.1007/s00428-012-1250-y (2012).
52. Turner, N. &Grose, R. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer 10, 116-129, doi:10.1038/nrc2780 (2010).
53. Meijer, G. A. et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J. Clin. Pathol. 51, 901-909 (1998). (Pubitemid 29005291)
54. Arbieva, Z. H. et al. High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22. Genome Res. 10, 244-257 (2000). (Pubitemid 30119593)
55. Sparano, A. et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 116, 735-741, doi:10.1097/01.mlg.0000205141.54471.7f (2006). (Pubitemid 44318029)
56. Paterson, I. C., Eveson, J. W. &Prime, S. S. Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur. J. Cancer. B Oral Oncol. 32B, 150-153 (1996).
57. Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90-94, doi:10.1038/nature09807 (2011).
58. Marusyk, A., Almendro, V. &Polyak, K. Intra-tumour heterogeneity: a looking glass for cancer? Nat. Rev. Cancer 12, 323-334, doi:10.1038/nrc3261 (2012).
59. Walker, D. M., Boey, G. &McDonald, L. A. The pathology of oral cancer. Pathology 35, 376-383, doi:9NLGYYNG3DJ0DN0R [pii] (2003). (Pubitemid 37310977)
60. Mu, D. et al. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3, 297-302 (2003). (Pubitemid 37443884)